Monday, 16 September 2019

Pharma News

  • Sucampo, Abbott launch Amitiza in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Sucampo Pharmaceuticals and Abbott have launched Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases...Read more

  • India clears Mylan's $760 mn acquisition deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

    Singapore: The Indian Cabinet Committee on Economic Affairs (CCEA) gave its final clearance to US-based Mylan to acquire Indian company Agila Specialties on September 3. The $760 million ac...Read more

  • Xiangxue Pharma acquires rights for Kinex KX02

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to Kinex's KX02 for all oncology indications i...Read more

  • Lipitor leads in Australia

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

  • Chinese, Hong Kong scientists map H7N9 risk infection

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine future risk and advis...Read more

  • AstraZeneca, Alchemia sign $240 mn drug deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

    Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

  • Merck shuts 2 sites, to further axe 1,100 staff

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: Merck plans to terminate around 1,100 of its 10,900 staff  in Germany by the end of 2015. Merck signed an agreement with employee representatives on an efficiency plan for the c...Read more

  • India's Orchid Pharma completes debt recast

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Indian company, based in Chennai, Orchid Chemicals and Pharmaceuticals has said that it completed the debt recast scheme that it had initiated last year. As per the process, Orc...Read more

  • Lilly reveals phase III trial data on back pain

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rDNA origin injection) and risedronate on back pain in postmenopausal w...Read more

  • Novartis heart drug gets FDA breakthrough grant

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: The US FDA granted breakthrough therapy designation status to Novartis RLX030 (serelaxin), an investigational treatment for patients with acute heart failure (AHF), as it substan...Read more

  • Vifor and Zeria sign deal for Ferinject in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Swiss-based Vifor Pharma, a company of the Galenica Group, has entered into an exclusive licensing agreement with Zeria Pharmaceutical for the development and commercialization o...Read more

  • Takeda's diabetes drug gets Chinese FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has issued them an Import Drug License (IDL) for Nesina (alopliptin) for ...Read more

  • Guangzhou records a whopping growth of over 50%

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognized name in China, Guangzhou Pharmaceutical Holdings is principally eng...Read more

  • What bioscience trends do the industry leaders predict for 2013?

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends that were so far just talk in the laboratories. First and foremost, ...Read more

  • Eisai gets approval for Halaven in Australia

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Department of Health and Aging to market its anticancer agent Halaven (eribul...Read more

  • FDA to ease rules on Alzheimer's drugs

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: The US Food and Drug Administration (FDA) is planning to ease the rules that govern the approval of new treatments for Alz­heimer's disease. The plan, which has been published i...Read more

  • Pharmaxis for Prix Galien UK award

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2014

    Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan Drug Award, that covers innovations in pharmaceutical R&D. Austral...Read more

  • How to get your drug registered in Taiwan?

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

    The life sciences sector in Asia Pacific (APAC) provides many opportunities for organizations that are looking for growth. Regulatory approvals are, however, an ardent task for these firms ...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls